title: Aberrations identified by genomic arrays in normal karyotype CMML can be detected in 40% of patients, but do not add prognostic information to molecular mutations.
authors.affiliation: MLL, Munich Leukemia Laboratory, Munich, Germany.|Division of Hematology, Department of Medical and Surgical Specialities, University of Catania, Catania, Italy.
authors.forename: C
authors.initials: C
authors.lastname: Vetro
authors.affiliation: MLL, Munich Leukemia Laboratory, Munich, Germany.
authors.forename: C
authors.initials: C
authors.lastname: Haferlach
authors.affiliation: MLL, Munich Leukemia Laboratory, Munich, Germany.
authors.forename: T
authors.initials: T
authors.lastname: Haferlach
authors.affiliation: MLL, Munich Leukemia Laboratory, Munich, Germany.
authors.forename: M
authors.initials: M
authors.lastname: Zenger
authors.affiliation: MLL, Munich Leukemia Laboratory, Munich, Germany.
authors.forename: N
authors.initials: N
authors.lastname: Nadarajah
authors.affiliation: MLL, Munich Leukemia Laboratory, Munich, Germany.
authors.forename: W
authors.initials: W
authors.lastname: Kern
authors.affiliation: MLL, Munich Leukemia Laboratory, Munich, Germany.
authors.forename: M
authors.initials: M
authors.lastname: Meggendorfer
mesh_terms: D000368:Aged; D002869:Chromosome Aberrations; D005260:Female; D006801:Humans; D007621:Karyotyping; D015477:Leukemia, Myelomonocytic, Chronic / Q000235:genetics*; D019656:Loss of Heterozygosity; D008297:Male; D009154:Mutation; D011379:Prognosis